Acquisition of Glucose 1.5% Injectable Solution Tender - 142209000

Procurement Summary

Country: Brazil

Summary: Acquisition of Glucose 1.5% Injectable Solution Bag 5000 Ml, Enoxaparin (Sodic) 60 Mg Injectable Solution 0.6 Ml Syringe, Enoxaparin (Sodic) 40 Mg Sol Inj Syringe 0.4 Ml (*), Enoxaparin (Sodium) 20 M...

Deadline: 11 Jun 2026

Posting Date: 28 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 142209000

Document Ref. No.: 90367/2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Object: Electronic Auction - Acquisition of GLUCOSE 1.5% INJECTABLE SOLUTION BAG 5000 ML, ENOXAPARIN (SODIUM) 60 MG INJECTABLE SOLUTION SYRINGE 0.6 ML, ENOXAPARIN (SODIUM) 40 MG SOL INJ SYRINGE 0.4 ML (*), ENOXAPARIN (SODIUM) 20 MG SOL INJ SYRINGE 0.2 ML (*), CONCENTRATED ACID SOLUTION FOR HEMODIALYSIS 3 MEQ OF CALCIUM, CONCENTRATED ACID SOLUTION FOR HEMODIALYSIS 2.5 MEQ OF CALCIUM, ISOSORBIDE (MONONITRATE) 40 MG TABLET, SPIRONOLACTONE 25 MG TABLET, FLUOXETINE 20 MG TABLET, OXCARBAZEPINE 300 MG Code of UASG: 92301 Notice from: 05/28/2026 from 08:00 to 17:59 Proposal Delivery: from 05/28/2026 at 08:00 SOLUTION FOR PERITONEAL DIALYSIS, COMPOSITION GLUCOSE, SODIUM, CALCIUM, MAGNESIUM, CHLORIDE, LACTATE, CONCENTRATION 1 ABOUT 1.5% + 135 MEQ/L + 3.5 MEQ/L + 1 MEQ/L, CONCENTRATION 2 100 MEQ/L + 40 MEQ/L, ADDITIONAL CHARACTERISTICS IN CLOSED SYSTEM Quantity: 454 ENOXAPARIN, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS 1 FILLED SYRINGE Quantity: 219662 ENOXAPARIN, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS 1 FILLED SYRINGE Quantity: 486960 ENOXAPARIN, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS 1 FILLED SYRINGE Quantity: 53904 SOLUTION FOR HEMODIALYSIS, COMPONENTS SODIUM, POTASSIUM, CALCIUM, MAGNESIUM, ADDITIONAL COMPONENTS CHLORIDE, ACETATE, BICARBONATE, CONCENTRATION 138 MEQ/L +2 MEQ/L + 3.5 MEQ/L + 1 MEQ/L, CONCENTRATION 1 109.5 MEQ/L + 3 MEQ/L + 32 MEQ/ L, PHARMACEUTICAL FORM APIROGENIC STERILE SOLUTION, ACID ADDITIONAL Quantity: 19546 SOLUTION FOR HEMODIALYSIS, COMPONENTS SODIUM, POTASSIUM, CALCIUM, MAGNESIUM, GLUCOSE, CONCENTRATION 138 MEQ/L + 2 MEQ/L + 3 MEQ/L + 106 MEQ/L + 5.5 MEQ/L, FORM PHARMACEUTICAL APIROGENIC STERILE SOLUTION, ADDITIONAL ACID Quantity: 5424 ISOSORBIDE, ACTIVE INGREDIENT MONONITRATE SALT, DOSAGE 40 MG...

Documents

 Tender Notice